The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of ...

Investigators studied cardiotoxicities of first-line regimens for metastatic hormone-sensitive and nonmetastatic castration-resistant prostate cancer.

It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

Opens in a new tab or window In metastatic ... ADT-free treatment strategies. "We look forward to seeing whether PSMA-RLTs [radioligand therapies] will be used across the prostate cancer disease ...

Bertram Yuh, MD, MISM, MSHCPM, discussed how single-port robotic surgery has changed treatment paradigms for patients with ...

Discover new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for ...

According to findings from the TALAPRO-2 study, the combination led to significant and meaningful improvements in overall ...

Sarasota Memorial Research Institute remains committed to advancing medical research and improving patient care through ...

BriaCell Therapeutics could access a $1-$5 billion market upon approval despite a sub-$30 million cap. See more on BRIA stock ...